If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 171 - 180 of 268
REACT-AF: Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
Objective
REACT-AF Monitoring AFib
Protocol No
CVC-JH-REACT-AF
Categories
Randomized Evaluation of Bromocriptine In Myocardial Recovery THerapy for Peripartum Cardiomyopathy (REBIRTH)
Objective
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy
Protocol No
CVC-NHLBI-REBIRTH
Categories
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial
Objective
Revascularization Choices Among under-Represented Groups Evaluation
Protocol No
CVC-PCORI-RECHARGE-M
Categories
Cerebral Protection in Transcatheter Aortic Valve Replacement: The PROTEMBO Trial
Objective
Cerebral Protection in Transcatheter Aortic Valve Replacement
Protocol No
CVC-PROTEMBIS-PROTEMBO
Categories
A Randomized, Phase II Clinical Trial of Stereotactic Body Radiation Therapy or Conventionally Fractionated Concurrent Chemotherapy and Radiation Therapy Preoperatively for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Ad
Objective
SOFT Preop Study, SBRT or Fractionated Therapy
Protocol No
IIT-HALL-SOFT-PRE-OP
Categories
A Phase 3, Multicenter, Randomized, Open-Label Study of Ifinatamab Deruxtecan (I-DXd), a B7-H3 Antibody Drug Conjugate (ADC), Versus Treatment of Physician's Choice (TPC) in Subjects with Relapsed Small Cell Lung Cancer (SCLC) (IDeate-2)
Objective
Study of ifinatamab deruxtecan in subjects with relapsed small cell lung cancer
Protocol No
DAIICHI-DS7300-188
Categories
Sex-specific Effects of Continuous Estrogen on Human in vivo Microvascular Function
Objective
Estrogen and Microvascular Function
Protocol No
ANES-IIT-FREED-ESTROGEN
Categories
Metaboreflex in Stroke Survivors
Objective
Metaboreflex in Stroke Survivors
Protocol No
ANES-IIT-DURAND-METABOREFLEX
Blood Flow Regulation and Neuromuscular Function Post-Stroke
Objective
Blood Flow Post Stroke
Protocol No
ANES-IIT-DURANT-BLOOD-FLOW
An open-label, randomized, parallel group, non-inferiority study to investigate the pharmacokinetics, pharmacodynamics, safety and tolerability of a new maintenance dosing regimen of ofatumumab, followed by extended treatment in participants with rel
Objective
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab (FILIOS)
Protocol No
NEURO-NOVARTIS-FILIOS